Compare Medtronic PLC (MDT) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Verizon Communications Inc — how do they compare? Medtronic PLC trades at $82.49 (market cap $106.61B), while Verizon Communications Inc trades at $43.28 (market cap $181.64B). The key difference: Verizon Communications Inc is the larger of the two by market cap, and Verizon Communications Inc pays the higher dividend (6.51%). Which is the better fit depends on your goals.
| MDT | VZ | |
|---|---|---|
Market Cap | $106.61B | $181.64B |
Sector | Health | Media |
52-Week High | $105.35 | $51.38 |
52-Week Low | $73.75 | $38.40 |
Enterprise Value | $125.36B | $369.14B |
Dividend Yield | 3.46% | 6.51% |
Volume | — | 22,584,735 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Verizon (VZ) trades at $43.51, down 0.19% on the day, with a bearish technical signal from moving averages but neutral oscillators. The stock shows strong fundamentals with a P/E of 10.63 and consistent earnings beats, including Q1 2026 EPS of $1.28 versus $1.21 expected. Recent news highlights a restructuring involving 3,000 job cuts and retail store divestitures to franchisees, aimed at improving efficiency. Cash flow from operations remains robust at $37.14 billion for 2025, supporting a dividend yield near 6.7%.
VZ offers value with low valuation multiples and a high dividend, but faces headwinds from intense wireless competition and execution risks in restructuring. Analyst consensus is a 'Hold' with a $48.06 price target, implying 10% upside. Key risks include debt levels and market saturation, while potential catalysts include successful cost-cutting and broadband growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
